- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CLR: CHOLESTEROL(Non-covalent)
- 50 x OCT: N-OCTANE(Non-functional Binders)(Non-covalent)
OCT.3: 1 residues within 4Å:- Ligands: OCT.4
Ligand excluded by PLIPOCT.4: 5 residues within 4Å:- Chain A: V.341, Y.486
- Ligands: OCT.3, D10.13, D10.14
Ligand excluded by PLIPOCT.5: 9 residues within 4Å:- Chain A: Y.204, V.492, L.496
- Chain B: L.497, I.500, Y.501
- Ligands: D10.13, D10.15, C14.86
Ligand excluded by PLIPOCT.6: 3 residues within 4Å:- Chain A: V.195
- Ligands: OCT.7, D10.17
Ligand excluded by PLIPOCT.7: 4 residues within 4Å:- Chain A: M.63, F.64, R.197
- Ligands: OCT.6
Ligand excluded by PLIPOCT.9: 4 residues within 4Å:- Chain A: F.241, Y.245, F.481
- Ligands: OCT.10
Ligand excluded by PLIPOCT.10: 7 residues within 4Å:- Chain A: F.241, T.474, V.477, I.494
- Ligands: D10.8, OCT.9, C14.30
Ligand excluded by PLIPOCT.18: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPOCT.20: 8 residues within 4Å:- Chain A: G.91, L.95, M.420, L.423, V.424, T.428, F.432
- Ligands: D10.19
Ligand excluded by PLIPOCT.25: 2 residues within 4Å:- Chain A: I.384
- Ligands: D12.24
Ligand excluded by PLIPOCT.28: 2 residues within 4Å:- Ligands: D10.29, C14.31
Ligand excluded by PLIPOCT.38: 4 residues within 4Å:- Chain A: L.262, G.263, L.266, M.267
Ligand excluded by PLIPOCT.40: 5 residues within 4Å:- Chain A: F.230, L.251, V.254
- Ligands: D10.36, D10.37
Ligand excluded by PLIPOCT.44: 2 residues within 4Å:- Chain A: Y.62
- Ligands: OCT.45
Ligand excluded by PLIPOCT.45: 3 residues within 4Å:- Chain A: L.71, F.125
- Ligands: OCT.44
Ligand excluded by PLIPOCT.46: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPOCT.47: 1 residues within 4Å:- Chain A: Y.74
Ligand excluded by PLIPOCT.48: 2 residues within 4Å:- Chain A: F.76, K.77
Ligand excluded by PLIPOCT.49: 1 residues within 4Å:- Chain A: V.80
Ligand excluded by PLIPOCT.50: 2 residues within 4Å:- Chain A: L.81
- Ligands: OCT.51
Ligand excluded by PLIPOCT.51: 3 residues within 4Å:- Chain A: P.287
- Ligands: OCT.50, OCT.53
Ligand excluded by PLIPOCT.52: 2 residues within 4Å:- Chain A: P.291, F.295
Ligand excluded by PLIPOCT.53: 7 residues within 4Å:- Chain A: V.85, I.88, S.89, A.288, P.289, P.291
- Ligands: OCT.51
Ligand excluded by PLIPOCT.54: 3 residues within 4Å:- Chain A: L.271, L.292, A.296
Ligand excluded by PLIPOCT.55: 3 residues within 4Å:- Chain A: F.269, G.270, E.277
Ligand excluded by PLIPOCT.58: 1 residues within 4Å:- Ligands: OCT.59
Ligand excluded by PLIPOCT.59: 5 residues within 4Å:- Chain B: V.341, Y.486
- Ligands: OCT.58, D10.68, D10.69
Ligand excluded by PLIPOCT.60: 9 residues within 4Å:- Chain A: L.497, I.500, Y.501
- Chain B: Y.204, V.492, L.496
- Ligands: C14.31, D10.68, D10.70
Ligand excluded by PLIPOCT.61: 3 residues within 4Å:- Chain B: V.195
- Ligands: OCT.62, D10.72
Ligand excluded by PLIPOCT.62: 4 residues within 4Å:- Chain B: M.63, F.64, R.197
- Ligands: OCT.61
Ligand excluded by PLIPOCT.64: 4 residues within 4Å:- Chain B: F.241, Y.245, F.481
- Ligands: OCT.65
Ligand excluded by PLIPOCT.65: 7 residues within 4Å:- Chain B: F.241, T.474, V.477, I.494
- Ligands: D10.63, OCT.64, C14.85
Ligand excluded by PLIPOCT.73: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPOCT.75: 8 residues within 4Å:- Chain B: G.91, L.95, M.420, L.423, V.424, T.428, F.432
- Ligands: D10.74
Ligand excluded by PLIPOCT.80: 2 residues within 4Å:- Chain B: I.384
- Ligands: D12.79
Ligand excluded by PLIPOCT.83: 2 residues within 4Å:- Ligands: D10.84, C14.86
Ligand excluded by PLIPOCT.93: 4 residues within 4Å:- Chain B: L.262, G.263, L.266, M.267
Ligand excluded by PLIPOCT.95: 5 residues within 4Å:- Chain B: F.230, L.251, V.254
- Ligands: D10.91, D10.92
Ligand excluded by PLIPOCT.99: 2 residues within 4Å:- Chain B: Y.62
- Ligands: OCT.100
Ligand excluded by PLIPOCT.100: 3 residues within 4Å:- Chain B: L.71, F.125
- Ligands: OCT.99
Ligand excluded by PLIPOCT.101: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPOCT.102: 1 residues within 4Å:- Chain B: Y.74
Ligand excluded by PLIPOCT.103: 2 residues within 4Å:- Chain B: F.76, K.77
Ligand excluded by PLIPOCT.104: 1 residues within 4Å:- Chain B: V.80
Ligand excluded by PLIPOCT.105: 2 residues within 4Å:- Chain B: L.81
- Ligands: OCT.106
Ligand excluded by PLIPOCT.106: 3 residues within 4Å:- Chain B: P.287
- Ligands: OCT.105, OCT.108
Ligand excluded by PLIPOCT.107: 2 residues within 4Å:- Chain B: P.291, F.295
Ligand excluded by PLIPOCT.108: 7 residues within 4Å:- Chain B: V.85, I.88, S.89, A.288, P.289, P.291
- Ligands: OCT.106
Ligand excluded by PLIPOCT.109: 3 residues within 4Å:- Chain B: L.271, L.292, A.296
Ligand excluded by PLIPOCT.110: 3 residues within 4Å:- Chain B: F.269, G.270, E.277
Ligand excluded by PLIP- 36 x D10: DECANE(Non-functional Binders)(Non-covalent)
D10.8: 2 residues within 4Å:- Ligands: CLR.2, OCT.10
Ligand excluded by PLIPD10.13: 7 residues within 4Å:- Chain A: I.348, D.485, Y.486, L.488, I.489
- Ligands: OCT.4, OCT.5
Ligand excluded by PLIPD10.14: 4 residues within 4Å:- Chain A: I.489
- Ligands: CLR.2, OCT.4, CLR.57
Ligand excluded by PLIPD10.15: 3 residues within 4Å:- Chain A: Y.204
- Chain B: Q.504
- Ligands: OCT.5
Ligand excluded by PLIPD10.17: 3 residues within 4Å:- Chain A: C.196
- Ligands: OCT.6, D12.16
Ligand excluded by PLIPD10.19: 3 residues within 4Å:- Chain A: V.298, T.301
- Ligands: OCT.20
Ligand excluded by PLIPD10.21: 3 residues within 4Å:- Chain A: L.419, L.423, L.426
Ligand excluded by PLIPD10.22: 1 residues within 4Å:- Ligands: D10.23
Ligand excluded by PLIPD10.23: 6 residues within 4Å:- Chain A: Y.118, L.325, L.326, P.327, F.388
- Ligands: D10.22
Ligand excluded by PLIPD10.29: 3 residues within 4Å:- Chain A: Y.501
- Ligands: OCT.28, C14.31
Ligand excluded by PLIPD10.32: 1 residues within 4Å:- Chain A: W.462
Ligand excluded by PLIPD10.33: 4 residues within 4Å:- Chain A: F.455, S.456, P.459
- Ligands: D10.34
Ligand excluded by PLIPD10.34: 4 residues within 4Å:- Chain A: M.453, F.455, S.456
- Ligands: D10.33
Ligand excluded by PLIPD10.35: 5 residues within 4Å:- Chain A: V.248, L.251, Q.252
- Ligands: HP6.27, D10.43
Ligand excluded by PLIPD10.36: 3 residues within 4Å:- Chain A: L.251
- Ligands: HP6.27, OCT.40
Ligand excluded by PLIPD10.37: 4 residues within 4Å:- Chain A: F.222, L.229, F.230
- Ligands: OCT.40
Ligand excluded by PLIPD10.39: 3 residues within 4Å:- Chain A: C.260, Y.313
- Ligands: HP6.41
Ligand excluded by PLIPD10.43: 2 residues within 4Å:- Ligands: HP6.27, D10.35
Ligand excluded by PLIPD10.63: 2 residues within 4Å:- Ligands: CLR.57, OCT.65
Ligand excluded by PLIPD10.68: 7 residues within 4Å:- Chain B: I.348, D.485, Y.486, L.488, I.489
- Ligands: OCT.59, OCT.60
Ligand excluded by PLIPD10.69: 4 residues within 4Å:- Chain B: I.489
- Ligands: CLR.2, CLR.57, OCT.59
Ligand excluded by PLIPD10.70: 3 residues within 4Å:- Chain A: Q.504
- Chain B: Y.204
- Ligands: OCT.60
Ligand excluded by PLIPD10.72: 3 residues within 4Å:- Chain B: C.196
- Ligands: OCT.61, D12.71
Ligand excluded by PLIPD10.74: 3 residues within 4Å:- Chain B: V.298, T.301
- Ligands: OCT.75
Ligand excluded by PLIPD10.76: 3 residues within 4Å:- Chain B: L.419, L.423, L.426
Ligand excluded by PLIPD10.77: 1 residues within 4Å:- Ligands: D10.78
Ligand excluded by PLIPD10.78: 6 residues within 4Å:- Chain B: Y.118, L.325, L.326, P.327, F.388
- Ligands: D10.77
Ligand excluded by PLIPD10.84: 3 residues within 4Å:- Chain B: Y.501
- Ligands: OCT.83, C14.86
Ligand excluded by PLIPD10.87: 1 residues within 4Å:- Chain B: W.462
Ligand excluded by PLIPD10.88: 4 residues within 4Å:- Chain B: F.455, S.456, P.459
- Ligands: D10.89
Ligand excluded by PLIPD10.89: 4 residues within 4Å:- Chain B: M.453, F.455, S.456
- Ligands: D10.88
Ligand excluded by PLIPD10.90: 5 residues within 4Å:- Chain B: V.248, L.251, Q.252
- Ligands: HP6.82, D10.98
Ligand excluded by PLIPD10.91: 3 residues within 4Å:- Chain B: L.251
- Ligands: HP6.82, OCT.95
Ligand excluded by PLIPD10.92: 4 residues within 4Å:- Chain B: F.222, L.229, F.230
- Ligands: OCT.95
Ligand excluded by PLIPD10.94: 4 residues within 4Å:- Chain B: V.259, C.260, Y.313
- Ligands: HP6.96
Ligand excluded by PLIPD10.98: 2 residues within 4Å:- Ligands: HP6.82, D10.90
Ligand excluded by PLIP- 10 x D12: DODECANE(Non-covalent)
D12.11: 6 residues within 4Å:- Chain A: I.189, C.192, T.333, F.336
- Ligands: HEX.26, D12.42
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:T.333, A:F.336
D12.12: 3 residues within 4Å:- Chain A: F.191, N.330, S.383
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.191
D12.16: 4 residues within 4Å:- Chain A: C.196, R.197, F.200
- Ligands: D10.17
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.200, A:F.200
D12.24: 3 residues within 4Å:- Chain A: P.328, N.330
- Ligands: OCT.25
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:P.328
D12.42: 3 residues within 4Å:- Chain A: H.337, I.344
- Ligands: D12.11
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:H.337, A:I.344
D12.66: 6 residues within 4Å:- Chain B: I.189, C.192, T.333, F.336
- Ligands: HEX.81, D12.97
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:T.333, B:F.336
D12.67: 3 residues within 4Å:- Chain B: F.191, N.330, S.383
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:F.191
D12.71: 4 residues within 4Å:- Chain B: C.196, R.197, F.200
- Ligands: D10.72
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:F.200, B:F.200
D12.79: 3 residues within 4Å:- Chain B: P.328, N.330
- Ligands: OCT.80
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:P.328
D12.97: 3 residues within 4Å:- Chain B: H.337, I.344
- Ligands: D12.66
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:H.337, B:I.344
- 2 x HEX: HEXANE(Non-covalent)
- 4 x HP6: HEPTANE(Non-covalent)
HP6.27: 7 residues within 4Å:- Chain A: V.243, V.244, T.247, L.251
- Ligands: D10.35, D10.36, D10.43
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:V.243, A:V.244, A:T.247, A:L.251
HP6.41: 5 residues within 4Å:- Chain A: G.263, M.267, F.307, L.309
- Ligands: D10.39
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.307, A:L.309
HP6.82: 7 residues within 4Å:- Chain B: V.243, V.244, T.247, L.251
- Ligands: D10.90, D10.91, D10.98
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:V.243, B:V.244, B:T.247, B:L.251
HP6.96: 6 residues within 4Å:- Chain B: G.263, V.264, M.267, F.307, L.309
- Ligands: D10.94
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:V.264, B:F.307, B:L.309
- 4 x C14: TETRADECANE(Non-covalent)
C14.30: 5 residues within 4Å:- Chain A: K.466, T.470, T.474
- Ligands: OCT.10, C14.31
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:K.466, A:T.470
C14.31: 7 residues within 4Å:- Chain A: K.466, I.467, Y.501
- Ligands: OCT.28, D10.29, C14.30, OCT.60
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:K.466, A:I.467, A:Y.501, A:Y.501
C14.85: 5 residues within 4Å:- Chain B: K.466, T.470, T.474
- Ligands: OCT.65, C14.86
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:K.466, B:T.470
C14.86: 7 residues within 4Å:- Chain B: K.466, I.467, Y.501
- Ligands: OCT.5, OCT.83, D10.84, C14.85
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:K.466, B:I.467, B:Y.501, B:Y.501
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ge, J. et al., Molecular mechanism of prestin electromotive signal amplification. Cell (2021)
- Release Date
- 2021-08-25
- Peptides
- Prestin: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CLR: CHOLESTEROL(Non-covalent)
- 50 x OCT: N-OCTANE(Non-functional Binders)(Non-covalent)
- 36 x D10: DECANE(Non-functional Binders)(Non-covalent)
- 10 x D12: DODECANE(Non-covalent)
- 2 x HEX: HEXANE(Non-covalent)
- 4 x HP6: HEPTANE(Non-covalent)
- 4 x C14: TETRADECANE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ge, J. et al., Molecular mechanism of prestin electromotive signal amplification. Cell (2021)
- Release Date
- 2021-08-25
- Peptides
- Prestin: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.